The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|18|2239-2248

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.18, 2004-07, pp. : 2239-2248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiparkinsonian Agents: Clinically Significant Drug Interactions and Adverse Effects, and Their Management

By Dalvi A.   Ford B.  

CNS Drugs, Vol. 9, Iss. 4, 1998-04 ,pp. : 291-310

Adis International

Access to resources Recommend Favorite

Drug-Induced Glaucomas: Mechanism and Management

By Tripathi R.C.   Tripathi B.J.   Haggerty C.  

Drug Safety, Vol. 26, Iss. 11, 2003-01 ,pp. : 749-767

Adis International

Access to resources Recommend Favorite

Drug-Induced Myelosuppression: Diagnosis and Management

By Carey P.J.  

Drug Safety, Vol. 26, Iss. 10, 2003-01 ,pp. : 691-706

Adis International

Access to resources Recommend Favorite

Drug-Induced Hypomagnesaemia: Scope and Management

By Atsmon Jacob   Dolev Eran  

Drug Safety, Vol. 28, Iss. 9, 2005-01 ,pp. : 763-788

Adis International

Access to resources Recommend Favorite

Extrapyramidal Symptoms with Atypical Antipsychotics: Incidence, Prevention and Management

By Pierre Joseph M.  

Drug Safety, Vol. 28, Iss. 3, 2005-01 ,pp. : 191-208

Adis International

Access to resources Recommend Favorite